North Korea vs Netherlands: Treatment for hypertension
North Korea
43.0%
in 2019
Netherlands
42.4%
in 2019
North Korea rank
95th
Netherlands rank
97th
Treatment for hypertension over time
- North Korea
- Netherlands
How they compare
North Korea currently reports 43.0% against 42.4% in Netherlands, a difference of 0.6%.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Netherlands ahead.
North Korea ranks 95th and Netherlands ranks 97th of 192 countries.
Across the 3 decades both report, North Korea averaged higher in 2 and Netherlands in 1.
Head to head by decade
| Decade | North Korea | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 21.1% | 23.9% | 2.8% | Netherlands |
| 2000s | 33.1% | 30.7% | 2.4% | North Korea |
| 2010s | 41.6% | 39.4% | 2.2% | North Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment for hypertension, North Korea or Netherlands?
- North Korea, at 43.0% against 42.4% in Netherlands as of 2019.
- What is the difference in treatment for hypertension between North Korea and Netherlands?
- 0.6%, with North Korea ahead.
- How many years of comparable data are there for North Korea and Netherlands?
- 30 years are reported by both, from 1990 to 2019.
- How do North Korea and Netherlands rank globally for treatment for hypertension?
- North Korea ranks 95th and Netherlands ranks 97th of 192 countries.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Treatment for hypertension (% of adults ages 30-79 with hypertension). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Treatment for hypertension is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.